Rule 3344-48-03 | Implementation of the program.
(A) Time frame: testing may occur anytime during the academic year, to include winter break and continue into the summer as applicable. Student-athletes shall be randomly selected for testing.
(B) Substances: the screening of substances may include, but is not limited to, the following:
(1) Amphetamines (including ecstasy)
(2) Anabolic steroids (HGH, syndopharb)
(3) Barbituates
(4) Cocaine
(5) Methaqualone
(6) Opiates (including heroin)
(7) PCP (angel dust) and analogues
(8) Tetrahydrocannabinol (THC, marijuana, synthetic marijuana)
(9) Alcohol
(10) Tobacco
(C) Many of the substances listed in paragraph (B) of this rule (and other banned substances) are found in dietary and herbal supplements. The CSU department of athletics and its personnel, in accordance with NCAA regulations, shall not distribute or encourage the use of any dietary supplements or ergogenic aids.
(D) Often, labeling of dietary supplements is not accurate and is misleading. Dietary supplements are not regulated by the food and drug administration (FDA) and, therefore, their purity is questionable.
(E) The use of dietary supplements may result in a positive drug test. Student-athletes who choose to use dietary supplements are encouraged to review the supplement with a member of the sports medicine department. Student-athletes are also encouraged to contact the national center for drug free sport, inc., at 877-202-0769 or www.drugfreesport.com/axis using the passcode NCAA1. Ultimate responsibility and accountability belongs to the student-athlete.
(F) Selection: student-athletes shall be selected randomly. Since the process is totally random, it is possible that the same individual may be selected on numerous occasions.
(G) Individuals who exhibit behavior symptomatic of drug usage may be selected independently of the random sample. A reasonable suspicion testing form may be completed by any concerned athletic department employee and reviewed with a member of the athletic training staff and/or head team physician or his/her designee. Any other university official or faculty member may bring his/her concerns about individual student-athletes to a member of the department of athletics senior staff or athletic training staff for discussion in consultation with the head team physician or his/her designee (appendix B).
(H) Any student-athlete who produced three or more dilute specimen samples during that original drug test, will automatically be tested at the next testing date under reasonable suspicion.
(I) There may be occasions where collaboration between the head team physician, head athletic trainer, head coach, and sport supervisor suggests the testing of an entire team. Under such circumstance and with the approval of the director of athletics, specific testing will not be randomized, but rather all-inclusive.
(J) All other implementation procedures, notifications, and reporting of results shall be handled according to this policy.
(1) Follow-up testing: A student-athlete who has returned to participation in intercollegiate sports following a positive drug test under this policy, may be subject to follow-up testing. Testing shall be unannounced and shall be required at a frequency determined by the director of athletics or his/her designee of the athletic director in consultation with the designated health care provider involved in the student-athlete's case.
(2) Pre-season screening: student-athletes are subject to pre-season drug testing and may be notified of such by the director of athletics or designee of the director of athletics or his/her designee at any time prior to their first competition.
(3) Transfer students: if it is brought to the attention of any sports medicine or Cleveland state university staff that a student-athlete transferring into Cleveland state university has history with prior positive drug test results with another university or with the NCAA, the student-athlete may be evaluated by the head team physician or authorized designee and may be submitted to non-random testing. However, no prior test results shall be considered as a first or subsequent positive test result for the purpose of the Cleveland state university drug education and screening program policy; however, the coach and/or sport supervisor may take that information under advisement for further sanctions.
(4) Notification: the student-athlete shall be notified of his/her selection for drug screening by a member of the CSU sports medicine staff or athletic department staff designee, which may include but is not limited to a coach or sport supervisor. This notification can occur at any time. At the time of notification, the student-athlete shall be presented with a student-athlete notification form, which indicates the date, time, and testing area. This form shall be signed by the student-athlete. Failure of the student-athlete to sign the form indicates an unwillingness to participate in the program and serves as a positive test result. Any refusal to participate in a required drug test, including not providing an adequate sample, leaving the testing area before providing an adequate sample, or failing to appear at the time of testing for any reason, shall be treated as a positive test and shall result in the penalties outlined in the CSU drug education and screening program policy (appendix C).
Supplemental Information